Biology:Mycoplasma penetrans
| Mycoplasma penetrans | |
|---|---|
Scientific classification 
| |
| Domain: | Bacteria |
| Phylum: | Mycoplasmatota |
| Class: | Mollicutes |
| Order: | Mycoplasmatales |
| Family: | Mycoplasmataceae |
| Genus: | Mycoplasma |
| Species: | M. penetrans
|
| Binomial name | |
| Mycoplasma penetrans Lo et al. 1992
| |
Mycoplasma penetrans is a species of Gram-positive bacteria.[1][2] It is pathogenic, though many infected show no symptoms. It is a sexually transmitted disease, though an infant may be infected during birth.[3][4]
Description
It has an elongated shape and its cells possess two internal compartments, one packed with granules, the other filled with coarse granules (consistent with ribosomal structures). The organism has properties of adherence through a specific organelle called the tip organelle. M. Penetrans has a coding sequence (MYPE1570) similar to that of MYPE470 in Mycoplasma pneumoniae which codes for an accessory protein that aids in cytadherence,[5] the adherence to respiratory epithelium. This similarity suggests M. penetrans could attach to host cells through cytadherence. Also, the CDS MYPE1550, which is near MYPE1570, of M. penetrans is orthologous to the hemadsorption protein HMW2 of M pneumoniae, suggesting the potential for M. penetrans to attach to and invade red blood cells.[5]
Virulence factors
Mycoplasma penetrans, like many bacteria, exhibits a mechanism by which it can avoid an immune response in the host cells. This avoidance of immune responses is known as a virulence factor. The virulence factor that M. penetrans displays is antigenic variation, the ability to exchange or switch antigens against which the host cell produces antibodies. The mpl gene encodes for the bacteria's antigens and, like most genes, it contains a promoter region. In M. penetrans, this promoter region can undergo reversible inversion, allowing for variation in antigen production and, thus, the source for M. penetrans antigenic variation.[6]
Diseases
Mycoplasma penetrans has been shown to hinder p53, a tumor suppressing gene that aids in regulating the cell cycle.[7] There have also been cases of malignant pleural effusion, when patients exhibited chronic M. penetrans infection with various immunodeficiencies (such as HIV infections or anticancer treatment).[8] This particular species is also a sexually transmitted disease and one cause of pelvic inflammatory disease.[9]
References
- ↑ Gallego, Pablo; Planell, Raquel; Benach, Jordi; Querol, Enrique; Perez-Pons, Joseph A.; Reverter, David (October 17, 2012). "Structural Characterization of the Enzymes Composing the Arginine Deiminase Pathway in Mycoplasma penetrans". PLOS ONE 7 (10): e47886. doi:10.1371/journal.pone.0047886. PMID 23082227. PMC 3474736. Bibcode: 2012PLoSO...747886G. http://ukpmc.ac.uk/journals/1217/. Retrieved 11 November 2014.
- ↑ Lo, S.-C.; Hayes, M. M.; Tully, J. G.; Wang, R. Y.-H.; Kotani, H.; Pierce, P. F.; Rose, D. L.; Shih, J. W.-K. (1992). "Mycoplasma penetrans sp. nov., from the Urogenital Tract of Patients with AIDS". International Journal of Systematic Bacteriology 42 (3): 357–364. doi:10.1099/00207713-42-3-357. ISSN 0020-7713. PMID 1503969.
- ↑ "Mycoplasma penetrans bacteremia and primary antiphospholipid syndrome". Emerging Infectious Diseases 5 (1): 164–7. 1999. doi:10.3201/eid0501.990122. PMID 10081687.
- ↑ Ljubin-Sternak, Sunčanica; Meštrović, Tomislav (2014). "Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Healthogens with an Impact on Human Reproductive Health". Journal of Pathogens 2014: 183167. doi:10.1155/2014/183167. PMID 25614838.
- ↑ 5.0 5.1 Sasaki, Y.; Ishikawa, J.; Yamashita, A.; Oshima, K.; Kenri, T.; Furuya, K.; Hattori, M (2002-12-01). "The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans". Nucleic Acids Research 30 (23): 5293–5300. doi:10.1093/nar/gkf667. ISSN 1362-4962. PMID 12466555.
- ↑ Horino, A.; Sasaki, Y.; Sasaki, T.; Kenri, T. (2003-01-01). "Multiple Promoter Inversions Generate Surface Antigenic Variation in Mycoplasma penetrans". Journal of Bacteriology 185 (1): 231–242. doi:10.1128/jb.185.1.231-242.2003. ISSN 0021-9193. PMID 12486060.
- ↑ Logunov, D Y; Scheblyakov, D V; Zubkova, O V; Shmarov, M M; Rakovskaya, I V; Gurova, K V; Tararova, N D; Burdelya, L G et al. (2008-04-14). "Mycoplasma infection suppresses p53, activates NF-κB and cooperates with oncogenic Ras in rodent fibroblast transformation". Oncogene 27 (33): 4521–4531. doi:10.1038/onc.2008.103. ISSN 0950-9232. PMID 18408766.
- ↑ Cao, Shuyan; Shen, Dandan; Wang, Yadong; Li, Linxi; Zhou, Liping; Wang, Yuxue (2017-07-10). "Potential malignant transformation in the gastric mucosa of immunodeficient mice with persistent Mycoplasma penetrans infection". PLOS ONE 12 (7): e0180514. doi:10.1371/journal.pone.0180514. ISSN 1932-6203. PMID 28692662. Bibcode: 2017PLoSO..1280514C.
- ↑ Ljubin-Sternak, Suncanica; Mestrovic, Tomislav (2014). "Review: Chlamydia trachonmatis and Genital Mycoplasmias: Pathogens with an Impact on Human Reproductive Health". Journal of Pathogens 2014 (183167): 183167. doi:10.1155/2014/183167. PMID 25614838.
Further reading
- Sasaki, Y. (2002). "The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans". Nucleic Acids Research 30 (23): 5293–5300. doi:10.1093/nar/gkf667. ISSN 1362-4962. PMID 12466555.
- Wang, R.Y.-H.; Hayes, M.M.; Wear, D.J.; Lo, S.C.; Shih, J.W.-K.; Alter, H.J.; Grandinetti, T.; Pierce, P.F. (1992). "High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients". The Lancet 340 (8831): 1312–1316. doi:10.1016/0140-6736(92)92493-Y. ISSN 0140-6736. PMID 1360035. https://zenodo.org/record/1258315.
External links
- LPSN
- Type strain of Mycoplasma penetrans at BacDive - the Bacterial Diversity Metadatabase
- Mycoplasma penetrans Genome Project
Wikidata ☰ Q3869048 entry
 |  |
